Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
Lancet
R Khatib, M McKee, H Shannon, C Chow, S Rangarajan, K Teo, L Wei, P Mony, V Mohan, R Gupta, R Kumar, K Vijayakumar, SA Lear, R Diaz, A Avezum, P Lopez-Jaramillo, F Lanas, K Yusoff, N Ismail, K Kazmi, O Rahman, A Rosengren, N Monsef, R Kelishadi, A Kruger, T Puone, A szuba, J Chifamba, A Temizhan, G Dagenais, A Gafni, S Yusuf
January 2016